Search company, investor...



Unattributed | Alive

Total Raised


Last Raised

$130K | 3 yrs ago

About SpineOvations

SpineOvations develops the next generation of minimally invasive treatments for back pain due to disc disease.

Headquarters Location

701 Palomar Airport Road Suite 30

Carlsbad, California, 92011,

United States

Missing: SpineOvations's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SpineOvations's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing SpineOvations

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SpineOvations is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,537 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

SpineOvations Patents

SpineOvations has filed 1 patent.

The 3 most popular patent topics include:

  • Bones of the vertebral column
  • Orthopedic surgical procedures
  • Surgical removal procedures
patents chart

Application Date

Grant Date


Related Topics




Surgical removal procedures, Bones of the vertebral column, Orthopedic surgical procedures, Neurosurgery, Clusters of differentiation


Application Date


Grant Date



Related Topics

Surgical removal procedures, Bones of the vertebral column, Orthopedic surgical procedures, Neurosurgery, Clusters of differentiation



Latest SpineOvations News

4 recent advancements in spinal biologics

Jun 12, 2020

Alan Condon - Here are four key developments in spinal biologics in the last month: Minimally invasive spine therapy company SpineOvations reported favorable results at the midpoint of its DiscSeal clinical trial. The viscous material, injected percutaneously into the intervertebral diseased disc, has demonstrated a reduction in lumbar pain, leg pain and disability. The European Commission approved Zolgensma, Novartis' $2.1 million gene therapy drug for spinal muscular atrophy, for infants and children up to 46 pounds. Zolgensma also gained approval in Japan, with decisions expected to be made by Swiss, Canadian and Australian authorities in late 2020 or early 2021. Orthobiologics company Cerapedics published data from a clinical trial examining the fusion rate of its i-Factor bone graft in noninstrumented lumbar fusion, Results indicated that older adult patients treated with i-Factor plus local bone achieved a higher fusion rate compared to allograft. The FDA granted biotechnology company Alume Biosciences permission to investigate the use of a nerve-imaging drug during spine surgery. Alume's ALM-488 peptide-dye conjugate is designed for real-time fluorescent highlighting of nerves during head and neck procedures. More articles on biologics:

SpineOvations Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SpineOvations Rank

SpineOvations Frequently Asked Questions (FAQ)

  • Where is SpineOvations's headquarters?

    SpineOvations's headquarters is located at 701 Palomar Airport Road, Carlsbad.

  • What is SpineOvations's latest funding round?

    SpineOvations's latest funding round is Unattributed.

  • How much did SpineOvations raise?

    SpineOvations raised a total of $130K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.